This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2003 May;52(5):342-6.

doi: 10.1007/s00262-002-0354-7. Epub 2003 Mar 14.

Antibody-mediated EGF receptor blockade as an anticancer therapy: from the laboratory to the clinic

John Mendelsohn¹

Affiliations

PMID: 12700950
PMCID: PMC11034287
DOI: 10.1007/s00262-002-0354-7

Review

Antibody-mediated EGF receptor blockade as an anticancer therapy: from the laboratory to the clinic

John Mendelsohn. Cancer Immunol Immunother. 2003 May.

. 2003 May;52(5):342-6.

doi: 10.1007/s00262-002-0354-7. Epub 2003 Mar 14.

Author

John Mendelsohn¹

Affiliation

¹ The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

PMID: 12700950
PMCID: PMC11034287
DOI: 10.1007/s00262-002-0354-7

No abstract available

PubMed Disclaimer

Similar articles

Anti-epidermal growth factor receptor antibodies in the treatment of metastatic colorectal cancer.
Lee D. Lee D. Clin Colorectal Cancer. 2004 Sep;4(3):159-62. doi: 10.1016/s1533-0028(11)70113-x. Clin Colorectal Cancer. 2004. PMID: 15377399 Review. No abstract available.
The ErbB receptors as targets for breast cancer therapy.
Albanell J, Baselga J. Albanell J, et al. J Mammary Gland Biol Neoplasia. 1999 Oct;4(4):337-51. doi: 10.1023/a:1018762216147. J Mammary Gland Biol Neoplasia. 1999. PMID: 10705918 Review.
[Molecular target therapy for colonic neoplasms].
Oki E, Ota M, Honbo T, Egashira A, Tokunaga E, Sadanaga N, Morita M, Kakeji Y, Maehara Y. Oki E, et al. Nihon Naika Gakkai Zasshi. 2007 Feb 10;96(2):289-94. doi: 10.2169/naika.96.289. Nihon Naika Gakkai Zasshi. 2007. PMID: 17370595 Review. Japanese. No abstract available.
Dual mode of action of a human anti-epidermal growth factor receptor monoclonal antibody for cancer therapy.
Bleeker WK, Lammerts van Bueren JJ, van Ojik HH, Gerritsen AF, Pluyter M, Houtkamp M, Halk E, Goldstein J, Schuurman J, van Dijk MA, van de Winkel JG, Parren PW. Bleeker WK, et al. J Immunol. 2004 Oct 1;173(7):4699-707. doi: 10.4049/jimmunol.173.7.4699. J Immunol. 2004. PMID: 15383606
Role of an anti-epidermal growth factor receptor in treating cancer.
Waksal HW. Waksal HW. Cancer Metastasis Rev. 1999;18(4):427-36. doi: 10.1023/a:1006302101468. Cancer Metastasis Rev. 1999. PMID: 10855786 Review.

See all similar articles

Cited by

Molecular target approaches in head and neck cancer: epidermal growth factor receptor and beyond.
Harari PM, Wheeler DL, Grandis JR. Harari PM, et al. Semin Radiat Oncol. 2009 Jan;19(1):63-8. doi: 10.1016/j.semradonc.2008.09.009. Semin Radiat Oncol. 2009. PMID: 19028347 Free PMC article. Review.
Deregulated EGFR signaling during lung cancer progression: mutations, amplicons, and autocrine loops.
Gazdar AF, Minna JD. Gazdar AF, et al. Cancer Prev Res (Phila). 2008 Aug;1(3):156-60. doi: 10.1158/1940-6207.CAPR-08-0080. Cancer Prev Res (Phila). 2008. PMID: 19138950 Free PMC article. No abstract available.
Inhibition of EGFR signaling: all mutations are not created equal.
Gazdar AF, Minna JD. Gazdar AF, et al. PLoS Med. 2005 Nov;2(11):e377. doi: 10.1371/journal.pmed.0020377. Epub 2005 Nov 29. PLoS Med. 2005. PMID: 16288556 Free PMC article.
Evaluating the efficacy of the anticancer drug cetuximab by atomic force microscopy.
Zhang Q, Shi Y, Xu H, Zhou L, Gao J, Jiang J, Cai M, Shan Y. Zhang Q, et al. RSC Adv. 2018 Jun 13;8(39):21793-21797. doi: 10.1039/c8ra03215g. eCollection 2018 Jun 13. RSC Adv. 2018. PMID: 35541738 Free PMC article.
A novel approach in the treatment of neuroendocrine gastrointestinal tumours. Targeting the epidermal growth factor receptor by gefitinib (ZD1839).
Höpfner M, Sutter AP, Gerst B, Zeitz M, Scherübl H. Höpfner M, et al. Br J Cancer. 2003 Nov 3;89(9):1766-75. doi: 10.1038/sj.bjc.6601346. Br J Cancer. 2003. PMID: 14583782 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources